Bailey Peck

About Bailey Peck

Results-driven Medical Affairs leader with over a decade of experience in biopharmaceutical strategy, cross-functional leadership, and therapeutic development. Adept at aligning medical affairs strategies with global corporate goals, managing multimillion-dollar budgets, and fostering high-impact collaborations with internal and external stakeholders. Proven success in driving medical education, strategic publications, and competitive intelligence initiatives that enhance HCP engagement and improve patient outcomes. Expert at leading teams, ensuring compliance in promotional materials, and delivering data-driven insights that shape product development, marketing, and market positioning. Passionate about advancing patient access to novel therapeutics, with a focus on rare and orphan diseases.

Experience

1. Director, Medical Affairs, Rare Diseases

   Ipsen

   Mar 2025 — Present · Las Vegas, NV, US

   As Director of Medical Affairs for Rare Disease at Ipsen, I lead the development and execution of U.S. medical strategy for rare liver conditions, working cross-functionally to ensure scientific rigor, strategic alignment, and patient-centered impact.My role spans a wide range of activities: I direct advisory boards and external education programs, partner with MSLs to enhance KOL engagement, and ensure that all medical and promotional materials meet the highest standards of scientific accuracy and compliance. I also provide strategic oversight for U.S-based clinical research initiatives and help shape our publication strategy alongside the global Medical and Publications teams.Highlights include- Leading U.S. field medical strategy and cross-functional medical initiatives in support of Bylvay- Strengthening KOL and stakeholder engagement through training, scientific exchange, and collaborative research efforts- Driving development of medical content for congresses, advisory boards, and internal training- Reviewing and approving medical education grants and clinical study proposals that align with strategic priorities- Mentoring MSLs and supporting internal teams with timely, accurate scientific information.I’m passionate about ensuring that patients with rare liver diseases are supported by strong, evidence-based medical strategies—and that our teams are equipped with the tools and insights to make a difference.

Education

• Colorado College

  Bachelor of Arts (B.A.)

  2006 — 2010

• The University of North Carolina at Chapel Hill

  Doctor of Philosophy (Ph.D.)

  2012 — 2016